Scarica l'app Stockscreener
123.86
0.68%
-0.28
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GILD Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Gilead Sciences Inc Borsa (GILD) Ultime notizie
Universal Beteiligungs und Servicegesellschaft mbH Lowers Position in Gilead Sciences, Inc. $GILD - MarketBeat
Migdal Insurance & Financial Holdings Ltd. Makes New Investment in Gilead Sciences, Inc. $GILD - MarketBeat
US Stocks Recap: What is the PEG ratio of Gilead Sciences IncPrice Action & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Gilead Sciences: Margin Expansion And Cash Flow Strength Underpriced (NASDAQ:GILD) - Seeking Alpha
The Truth About Gilead Sciences Inc: Why Everyone Is Suddenly Watching This Stock - AD HOC NEWS
Bernstein reiterates Outperform rating on Gilead stock with $135 price target - Investing.com
Gilead Sciences, Inc. $GILD Shares Acquired by Wealth Enhancement Advisory Services LLC - MarketBeat
Royal Bank Of Canada Forecasts Strong Price Appreciation for Gilead Sciences (NASDAQ:GILD) Stock - MarketBeat
40 Under 40: Calvin Yan Ting Chan, Gilead Sciences - Medical Marketing and Media
Stocks Generating Improved Relative Strength: Gilead Sciences - Investor's Business Daily
Gilead Sciences Earnings Outlook: Key Points to Watch - Bitget
Lobbying Update: $30,000 of TIBER CREEK GROUP ON BEHALF OF GILEAD SCIENCES INC. lobbying was just disclosed - Quiver Quantitative
Gilead Sciences Earnings Preview: What to Expect - Barchart.com
Gilead Sciences, Inc. (NASDAQ:GILD) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Allstate Corp Grows Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences (NASDAQ:GILD) Nasdaq Futures Spotlight Biopharma Scale - Kalkine Media
Csenge Advisory Group Has $2.38 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Campbell & CO Investment Adviser LLC Invests $1.40 Million in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Sold by QRG Capital Management Inc. - MarketBeat
HER2-Negative Metastatic Breast Cancer Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Genentech, AstraZeneca, Merck Sharp & Dohme LLC, Gilead Sciences, BeiGene, Eisai - Barchart.com
Insider Sell: Andrew Dickinson Sells 3,000 Shares of Gilead Scie - GuruFocus
Andrew Dickinson Sells 3,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock - MarketBeat
Gilead Sciences (NASDAQ:GILD) Insider Johanna Mercier Sells 3,000 Shares of Stock - MarketBeat
Gilead Sciences CCO Mercier sells $372,930 in stock - Investing.com
Gilead Sciences CFO Dickinson sells $372,930 in stock - Investing.com India
The Truth About Gilead Sciences: Is This ‘Boring’ Pharma Stock About To Blow Up? - AD HOC NEWS
Hedge Fund Moves: Whats the analyst consensus on Gilead Sciences IncWeekly Profit Recap & Fast Gain Stock Tips - baoquankhu1.vn
Gilead: A Top GARP Biotech Play, But Momentum Weakens (Downgrade) (NASDAQ:GILD) - Seeking Alpha
Looking Into Gilead Sciences Inc's Recent Short Interest - Benzinga
Gilead Sciences, Inc. $GILD Shares Purchased by Ritholtz Wealth Management - MarketBeat
GILD Stock Price, Forecast & Analysis | GILEAD SCIENCES INC (NASDAQ:GILD) - Chartmill
Short Covering: Is GCTSWS stock a good pick for beginnersJuly 2025 Chart Watch & Expert Approved Trade Ideas - baoquankhu1.vn
Gilead stock holds Buy rating at UBS as Yeztugo launch shows promise - Investing.com
Gilead Sciences, Inc. $GILD Shares Sold by Conning Inc. - MarketBeat
JPM26: Gilead Captures Sunny JPM Mood With Yeztugo Numbers, HIV Vibes - BioSpace
Gilead Sciences, Inc. (GILD) Stock Analysis: Strong Buy Ratings and 10.84% Potential Upside - DirectorsTalk Interviews
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Manning & Napier Advisors LLC Has $13.65 Million Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences CFO Andrew Dickinson sells $14 million in stock - MSN
A Look At Gilead Sciences (GILD) Valuation After JP Morgan Conference HIV Pipeline Update - Sahm
GILD: Morgan Stanley Lowers Price Target for Gilead Sciences | G - GuruFocus
Morgan Stanley Issues Pessimistic Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price - MarketBeat
Gilead Sciences stock rating reiterated at Outperform by BMO Capital - Investing.com
Nordea Investment Management AB Has $494.03 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Acquired by TD Private Client Wealth LLC - MarketBeat
Liberty One Investment Management LLC Increases Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Acquired by PKO Investment Management Joint Stock Co - MarketBeat
Polaris Capital Management LLC Sells 12,500 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead price tries to regain footingForecast today13-01-2026 - Economies.com
Kymera Therapeutics Outlines Key 2026 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs - GlobeNewswire Inc.
Gilead Sciences, Inc. (NASDAQ:GILD) Is a Favorite Amongst Institutional Investors Who Own 88% - 富途牛牛
Gilead Sciences (GILD) Surpasses Market Returns: Some Facts Worth Knowing - sharewise.com
Gilead Expects FDA Decision on Anito-Cel in First Quarter of 2026 - Precision Medicine Online
Gilead Sciences: From All-Time Highs To Higher Highs (NASDAQ:GILD) - Seeking Alpha
Gilead’s new HIV prevention shot added to CVS’s drug coverage lists, CEO says - 104.1 WIKY
Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says - Reuters
Gilead Sciences to Seek Bolt-On Value-Creating Acquisitions - marketscreener.com
Sumitomo Mitsui Trust Group Inc. Buys 27,232 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Meeder Asset Management Inc. Has $16.76 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Nexus Investment Management ULC Buys 21,220 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Tema Etfs LLC Buys 25,912 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Inside Gilead’s 2030 Strategy to Advance 10 Transformative Therapies - Endpoints News
9,809 Shares in Gilead Sciences, Inc. $GILD Bought by Elite Wealth Management Inc. - MarketBeat
First Horizon Corp Takes $8.02 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
UBS and Citi Go Bullish on Gilead Sciences (GILD) - Insider Monkey
The Bull Case For Gilead Sciences (GILD) Could Change Following New OncoNano Drug-Delivery Collaboration - Yahoo Finance
Is Gilead Sciences (GILD) Pricing Reflecting Recent 38.5% One Year Share Return? - Yahoo Finance
New York State Teachers Retirement System Has $121.45 Million Stake in Gilead Sciences, Inc. $GILD - MarketBeat
0.07%
3.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):